SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
14-Feb-24 4:29 PM View: | Eli Lilly & Co. (LLY) | 12-Feb-24 | Grant | 4,790 | $737.26 | $3,531,480.00 | 32% 15.01K to 19.8K | |
02-Feb-24 4:29 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-24 | Payment of Exercise | 1,664 | $645.61 | $1,074,300.00 | (10%) 16.68K to 15.01K | |
02-Feb-24 4:29 PM View: | Eli Lilly & Co. (LLY) | 01-Feb-24 | Option Exercise | 3,702 | -- | -- | 29% 12.97K to 16.68K | |
14-Feb-23 5:19 PM View: | Eli Lilly & Co. (LLY) | 10-Feb-23 | Grant | 1,350 | $345.12 | $465,912.00 | 12% 11.62K to 12.97K | |
17-Feb-22 4:40 PM View: | Eli Lilly & Co. (LLY) | 16-Feb-22 | Market Sale (Planned) | 1,000 | $242.58 | $242,580.00 | (8%) 12.62K to 11.62K | (7%) |
17-Feb-22 4:40 PM View: | Eli Lilly & Co. (LLY) | 15-Feb-22 | Market Sale (Planned) | 1,000 | $237.45 | $237,450.00 | (7%) 13.62K to 12.62K | (10%) |
11-Feb-22 6:42 PM View: | Eli Lilly & Co. (LLY) | 09-Feb-22 | Grant | 3,275 | $243.27 | $796,709.00 | 32% 10.35K to 13.62K | 7% |
10-Feb-21 8:50 PM View: | Eli Lilly & Co. (LLY) | 08-Feb-21 | Grant | 3,536 | $205.77 | $727,603.00 | 52% 6.81K to 10.35K | (2%) |